Core Scientific (CORZ) Other financing activities (2021 - 2026)

Core Scientific has disclosed Other financing activities across 4 years of filings, most recently posting $77000.0 for Q2 2026.

• In Q2 2026, Other financing activities fell 74.33% year-over-year to $77000.0; the TTM figure through Jun 2026 stood at $6.4 million (up 38.49% YoY), while the FY2025 annual figure was $6.9 million, up 41.47% from the prior year.
• Other financing activities came in at $77000.0 for Q2 2026 at Core Scientific, down from $81000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $5.2 million in Q4 2025 to a low of $9000.0 in Q1 2024.
• Average Other financing activities over 3 years is $1.1 million, with a median of $350000.0 recorded in 2024.
• Year-over-year, Other financing activities surged 2855.56% in 2025 and plunged 74.33% in 2026.
• Over 3 years, Other financing activities stood at $3.0 million in 2024, then soared by 73.79% to $5.2 million in 2025, then sank by 98.51% to $77000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $77000.0 in Q2 2026, $81000.0 in Q1 2026, and $5.2 million in Q4 2025.